ELUTIA INC.
SILVER SPRING, MD

ELUTIA INC., originally known as AZIYO BIOLOGICS, INC., is a privately-held biotech company based in SILVER SPRING, FLORIDA, specializing in regenerative medicine. Founded by HighCape Partners in 2015, Aziyo Biologics is dedicated to restoring health and mobility for patients through innovative medical products across various fields like cardiology, orthopedics, and wound care. The company emphasizes strong scientific foundations, leveraging biology to create optimal biomaterials and utilizing clinical data as a guiding force in decision-making. Aziyo's mission centers on developing regenerative solutions that honor the generous spirit of organ donors while striving to maximize patient health outcomes. Their portfolio includes advanced osteobiologic products and truly regenerative cardiac device implantation solutions, all aimed at unlocking new possibilities within regenerative medicine. The company has achieved significant growth through strategic acquisitions and partnerships. Operating under the guidance of leaders such as Chief Executive Officer C.R. Mills, Director Kevin Rakin, and Vice President Jeffrey Hamet, ELUTIA INC. continues to focus on innovation with a commercial perspective. Their efforts are rooted in established corporate partnerships and profound expertise in product development and biologics processing. For more information, visit their website at aziyobiologics.com or contact them via their listed phone numbers.